RAIN - Rain Therapeutics Inc. (RAIN) CEO Avanish Vellanki On Q4 2021 Results - Earnings Call Transcript
Rain Therapeutics, Inc. (RAIN) Q4 2021 Earnings Conference Call March 3, 2022 4:30 PM ET Company Participants Kristy Grabowski - Director, Investor Relations Avanish Vellanki - Chief Executive Officer Richard Bryce - Chief Medical Officer Robert Doebele - Chief Scientific Officer Nelson Cabatuan - Senior Vice President, Finance Conference Call Participants Yigal Nochomovitz - Citigroup Yige Guo - Guggenheim Securities Joe Catanzaro - Piper Sandler Mansi Mittal - Goldman Sachs Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:00 Good day, and thank you for standing by. Welcome to the Business Highlights Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation
For further details see:
Rain Therapeutics, Inc. (RAIN) CEO Avanish Vellanki On Q4 2021 Results - Earnings Call Transcript